A cutting-edge pathology laboratory designed to serve patients across West Yorkshire has been officially opened by the Minister of State for Health and Secondary Care, Will Quince.
Bio-Rad Laboratories has announced the launch of its new PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR applications in basic and translational research, process development, and quality control.
Multiple myeloma diagnostics and monitoring company Sebia, has launched its new serum-based Minimal Residual Disease (MRD) test for monitoring in multiple myeloma. M-inSight is a laboratory developed test being offered by Corgenix (pictured) - a licensed clinical laboratory and part of the Sebia Group.
PCR Biosystems, a leading PCR reagent developer, has launched a new range of Bst polymerase reagents that offer greater sensitivity, speed, and specificity in all isothermal amplification applications.
Curenetics, Queen Mary University London (QMUL), Oracle Cancer Trust and South East Health Technologies Alliance (SEHTA) are working collaboratively to pioneer a transformative approach to oral cancer detection through the Novel AI-Enabled qMIDS Test. This groundbreaking project is poised to elevate precision cancer diagnostics by harnessing the power of artificial intelligence.
Revvity has unveiled its groundbreaking Pin-point base editing platform reagents, providing researchers with unparalleled access to implement the advanced gene editing technique in their preclinical laboratories.
On the first day of its biennial Congress, the Institute of Biomedical Science (IBMS) has published its Long Term Biomedical Scientist Workforce Plan, presenting a bold strategy for the UK to develop the biomedical scientist workforce to operate at the highest levels of practice through training, experience and professional qualifications.
Tasso has announced its Tasso+ pain-free blood lancet device that collects whole liquid blood samples, has received CE Mark certification.
Together with 34 national associations, MedTech Europe has sent an open letter to Commissioner for Health, Stella Kyriakides, regarding the need for comprehensive structural reform in the European regulatory framework for medical technologies (IVDR and MDR).
The NHS is still reliant on paper notes and drug charts despite electronic upgrades, a survey conducted by medical journal The BMJ has found.
A team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC; pictured) using image processing with deep learning.
The Innovative Devices Access Pathway (IDAP) pilot has been launched, supported by £10 million of Government funding, with the aim of expediting UK patient access to innovative technologies by providing innovators and manufacturers with multi-partner support and targeted scientific advice.
The British Journal of Biomedical Science is excited to announce a new award for biomedical Scientists at the start of their research career. The BJBS Publishing Prize aims to inspire biomedical scientists at the start of their research careers to submit their research to the journal.
Imaging firm Evident has announced an alliance with Corista, Sakura Finetek USA and Visiopharm to deliver an automated, end-to-end workflow solution for pathology in the USA. Together, the scientific leaders will combine their technologies to streamline the workflow of staining, imaging, and analysing whole slide images with the collaboration and management needed in today’s high-volume laboratories.
HORIBA UK has expanded its clinical chemistry portfolio with the addition of a new test kit for glucose-6-phosphate dehydrogenase (G6PD) from Pointe Scientific. Used for the quantitative determination of G6PD enzyme activity in blood, the CE-marked POINTE G6PD assay kit combines everything required for undertaking G6PD testing, excluding controls, in a single box.
The new BOND-PRIME Advanced Staining Solution from Leica Biosystems has its first event unveiling at this year’s IBMS Congress (stand 608). BOND-PRIME is a faster, more advanced staining solution, featuring all elements of Universal Access – able to handle any slide, in any combination, at any time, using any reagent.